163 related articles for article (PubMed ID: 3422172)
1. Prognostic significance of bone morphogenetic activity in osteosarcoma tissue.
Yoshikawa H; Takaoka K; Masuhara K; Ono K; Sakamoto Y
Cancer; 1988 Feb; 61(3):569-73. PubMed ID: 3422172
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of bone morphogenetic activity in osteosarcoma. A study of 20 cases.
Yoshikawa H; Takaoka K; Hamada H; Ono K
Cancer; 1985 Oct; 56(7):1682-7. PubMed ID: 3861232
[TBL] [Abstract][Full Text] [Related]
3. Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody.
Yoshikawa H; Rettig WJ; Takaoka K; Alderman E; Rup B; Rosen V; Wozney JM; Lane JM; Huvos AG; Garin-Chesa P
Cancer; 1994 Jan; 73(1):85-91. PubMed ID: 7506120
[TBL] [Abstract][Full Text] [Related]
4. Kissing pleural metastases from metastatic osteosarcoma of the lung.
Mori T; Yoshioka M; Iwatani K; Kobayashi H; Yoshimoto K; Nomori H
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):129-32. PubMed ID: 16702936
[TBL] [Abstract][Full Text] [Related]
5. Expression of bone morphogenetic proteins in human osteogenic and epithelial tumor cells.
Ogose A; Motoyama T; Hotta T; Watanabe H
Pathol Int; 1996 Jan; 46(1):9-14. PubMed ID: 10846544
[TBL] [Abstract][Full Text] [Related]
6. Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54.
Uribe-Botero G; Russell WO; Sutow WW; Martin RG
Am J Clin Pathol; 1977 May; 67(5):427-35. PubMed ID: 266360
[TBL] [Abstract][Full Text] [Related]
7. The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter.
Sulzbacher I; Birner P; Trieb K; Pichlbauer E; Lang S
J Clin Pathol; 2002 May; 55(5):381-5. PubMed ID: 11986346
[TBL] [Abstract][Full Text] [Related]
8. The effect of bone morphogenetic protein-2 on osteosarcoma metastasis.
Gill J; Connolly P; Roth M; Chung SH; Zhang W; Piperdi S; Hoang B; Yang R; Guzik H; Morris J; Gorlick R; Geller DS
PLoS One; 2017; 12(3):e0173322. PubMed ID: 28264040
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma.
Arihiro K; Inai K
Pathol Int; 2001 Feb; 51(2):100-6. PubMed ID: 11169148
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic response of various histological osteosarcoma subtypes to high-dose methotrexate treatment].
Schulz A; Fischer HP; Breithaupt H; Pralle H
Onkologie; 1983 Dec; 6(6):296-304. PubMed ID: 6366675
[TBL] [Abstract][Full Text] [Related]
12. A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice.
Crnalic S; Häkansson I; Boquist L; Löfvenberg R; Brostrom LA
Clin Exp Metastasis; 1997 Mar; 15(2):164-72. PubMed ID: 9062393
[TBL] [Abstract][Full Text] [Related]
13. Caffeine-potentiated chemotherapy for metastatic osteosarcoma.
Kimura H; Tsuchiya H; Shirai T; Nishida H; Hayashi K; Takeuchi A; Ohnari I; Tomita K
J Orthop Sci; 2009 Sep; 14(5):556-65. PubMed ID: 19802667
[TBL] [Abstract][Full Text] [Related]
14. Positron Emission Tomography Detects
Butch ER; Mead PE; Amador Diaz V; Tillman H; Stewart E; Mishra JK; Kim J; Bahrami A; Dearling JLJ; Packard AB; Stoddard SV; Vāvere AL; Han Y; Shulkin BL; Snyder SE
Cancer Res; 2019 Jun; 79(12):3112-3124. PubMed ID: 31015228
[TBL] [Abstract][Full Text] [Related]
15. Induction of new-bone formation in the host bed by human bone-tumor transplants in athymic nude mice.
Urist MR; Grant TT; Lindholm TS; Mirra JM; Hirano H; Finerman GA
J Bone Joint Surg Am; 1979 Dec; 61(8):1207-16. PubMed ID: 229105
[TBL] [Abstract][Full Text] [Related]
16. LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.
Yong BC; Lu JC; Xie XB; Su Q; Tan PX; Tang QL; Wang J; Huang G; Han J; Xu HW; Shen JN
Tumour Biol; 2017 Feb; 39(2):1010428317691188. PubMed ID: 28240050
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups.
Gok Durnali A; Paksoy Turkoz F; Ardic Yukruk F; Tokluoglu S; Yazici OK; Demirci A; Bal O; Gundogdu Buyukbas S; Esbah O; Oksuzoglu B; Alkis N
PLoS One; 2016; 11(5):e0152621. PubMed ID: 27167624
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
19. Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.
Lamora A; Mullard M; Amiaud J; Brion R; Heymann D; Redini F; Verrecchia F
Oncotarget; 2015 Jun; 6(16):14413-27. PubMed ID: 26015407
[TBL] [Abstract][Full Text] [Related]
20. Relation between histological intensity of transforming growth factor-beta isoforms in human osteosarcoma and the rate of lung metastasis.
Yang RS; Wu CT; Lin KH; Hong RL; Liu TK; Lin KS
Tohoku J Exp Med; 1998 Feb; 184(2):133-42. PubMed ID: 9605020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
